Emergent Biosolutions (EBS)
NYSE:EBS
Holding EBS?
Track your performance easily

Emergent Biosolutions (EBS) Cash flow

1,221 Followers

Emergent Biosolutions Cash Flow

EBS's free cash flow for Q3 2024 was $155.50M. For the 2024 fiscal year, EBS's free cash flow was decreased by $157.50M and operating cash flow was $153.70M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 170.70M$ -206.30M$ -34.10M$ 321.10M$ 536.00M$ 188.00M
Investing Cash Flow
$ 85.20M$ 212.30M$ -381.30M$ -225.00M$ -151.00M$ -96.90M
Financing Cash Flow
$ -185.80M$ -535.70M$ 481.20M$ -141.00M$ 69.50M$ -35.90M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 418.10M$ 111.70M$ 642.60M$ 576.30M$ 621.50M$ 168.00M
Income Tax Paid Supplemental Data
$ 50.00M$ 52.80M$ 6.20M$ 71.60M$ 109.30M$ 30.80M
Interest Paid Supplemental Data
$ 67.60M$ 68.30M$ 33.00M$ 30.40M$ 21.00M$ 34.50M
Issuance Of Capital Stock
$ 200.00K$ 8.40M----
Issuance Of Debt
$ -208.90M$ -543.40M$ 564.20M$ -35.90M$ 54.50M$ 13.70M
Repayment Of Debt
$ -512.90M$ -563.40M$ -33.80M$ -35.90M$ -395.50M$ -116.30M
Free Cash Flow
$ 145.70M$ -257.90M$ -415.40M$ 96.10M$ 395.00M$ 101.10M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Emergent Biosolutions Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis